Skip to main content
. 2021 Mar 17;21:173. doi: 10.1186/s12935-021-01869-0

Fig. 3.

Fig. 3

Forest plots for cancer/dysplasia risk among patients with type III IM when compared with type II + I IM (a), and with only type II IM (b). And cancer/dysplasia risk among patients with type II IM when compared with type I IM (c)